▶
Are We Ready for Psychedelics?
Late-stage clinical trials suggest psychedelic-based therapies to treat anxiety and depression will soon be available by prescription. Pharmaceutical companies are investing heavily in research and the White House has directed the FDA to put them on a fast track for review. But the road from clinical testing to marketing to broad use will be bumpy as we learn more about how psychedelics affect the brain, regulators develop a framework for assessing their safety and effectiveness, insurers consider whether to cover them, and healthcare providers seek out specialized training to ensure their proper use.
Aspen Ideas: Health takes place on the Aspen Institute’s wondrous 40-acre campus in the Rocky Mountains from June 22-25, 2026.
The three-day event, which has opened the renowned Aspen Ideas Festival since 2014, is where health’s biggest challenges meet its biggest thinkers. #AspenIdeasHealth #AspenIdeas
For more information about Aspen Ideas: Health, visit https://www.aspenideas.org/health.
